
Exclusive-Kennedy aide and vaccine critic questions recent expert recommendations
(Reuters) -An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a panel of outside experts last month, according to documents reviewed by Reuters and two sources familiar with the situation.
The advisory panel to the Centers for Disease Control and Prevention had made recommendations regarding the use of separate shots approved to help protect against RSV, meningitis and chikungunya. The CDC is not required to adopt their recommendations, but when it does, they become guidelines for medical practitioners to follow.
Dr. William 'Reyn' Archer III joined the Health and Human Services Department, which oversees CDC, as a counselor in the secretary's office after Kennedy took over in February, HHS records show. A critic of vaccines on social media for the past several years, Archer served as Texas state health commissioner in the late 1990s.
Archer's hiring and activity at HHS have not previously been reported. His role reviewing the Advisory Committee on Immunization Practices' recommendations is the latest indication of how Kennedy, who has spent decades raising doubts about the safety and efficacy of vaccines, is reshaping U.S. policy.
HHS spokesman Andrew Nixon said the agency "will ensure that all recommendations adhere to the Gold Standard of Science."
As part of his HHS role, Archer has in recent days posed questions to the CDC about the advisory committee recommendations, according to the documents and the two sources.
One recommendation would expand eligibility for RSV vaccines made by Pfizer and GSK to high-risk adults aged 50-59 from a current threshold age of at least 60 years.
In response, Archer asked for more justification of the expansion given what he described as a 'possible decline in efficacy with a second dose,' according to the documents and two sources.
It is unclear what decline in efficacy data Archer is referring to. At the ACIP meeting, a GSK representative presented clinical trial results the company described as showing 'robust' immune responses following re-vaccination at 24 and 36 months.
A GSK spokesperson said the data showed waning efficacy of a single dose over time, but not enough to justify revaccination yet. A Pfizer spokesperson did not immediately respond to requests for comment.
ACIP also voted to recommend expanded use of GSK's vaccine for meningitis, and Archer questioned how providers administer it.
In addition, ACIP recommended the use of a new chikungunya vaccine from Bavarian Nordic, which Archer has not disputed. However, Kennedy's aide asked for more information about a recommendation to expand the use of a vaccine for the mosquito-borne virus made by Valneva, the documents show.
Archer also asked to know what adjuvants and platforms are being used for all the vaccines discussed at the ACIP meeting, and their length of immunity.
FROM TEXAS TO WASHINGTON
Kennedy is currently reviewing the latest ACIP recommendations in the absence of a CDC director, and it is unclear whether the HHS secretary will ultimately sign off on them.
The decision will impact public health and major drug companies. Pfizer and GSK last month touted ACIP's vote to lower the age at which adults can be eligible for their respective RSV vaccines, decisions that affect whether insurers will likely pay for them. The FDA previously approved the age expansion.
Kennedy says he is not opposed to vaccination, but described them as a personal choice in the midst of a large U.S. measles outbreak mostly among the unvaccinated. Kennedy argues that the nation's health bureaucracy should focus on chronic illness.
Archer is a trained obstetrician who served in the early 1990s as a deputy assistant secretary of HHS under the administration of George H.W. Bush. At HHS, he helped implement a so-called gag rule restricting medical providers at federally-funded clinics from advising patients on abortion, according to court documents and media reports.
He was appointed by then-Texas Governor George W. Bush to serve as commissioner of the state's Department of Health. He resigned in 2000 after a Black administrator in the department secretly recorded him making comments about her race, according to an Associated Press report at the time.
Archer later served as chief of staff for Congressman Jeff Fortenberry of Nebraska from 2016 to 2022, according to his LinkedIn profile.
Fortenberry, who opposed COVID-19 vaccine mandates during his tenure, was subsequently charged with lying to federal authorities about a campaign donation. The Justice Department dropped those charges after President Donald Trump took office in January.
On his personal Facebook page, Archer posted repeatedly from 2020 to 2022 about the "limitations" of the COVID vaccine, Reuters found. In a deleted post on X, accessed with the Internet Archive, Archer said as Texas health commissioner he felt pressure to support vaccine mandates without "scientific counterfactual.'
"My own son developed autism in early years then took his life at 16," he said in the post, which linked to a Trump campaign ad critical of the measles vaccine.
Kennedy had long promoted a debunked link between vaccines and autism, contrary to scientific evidence, and last month promised a study to determine the cause of the condition.
(Reporting by Dan Levine in San Francisco and Leah Douglas in Washington; Editing by Michele Gershberg and Bill Berkrot)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
a day ago
- New Straits Times
Brain-eating amoeba linked to camper's death
TEXAS: A woman from the United States (US) died from an infection after using tap water from a recreational vehicle's water system at a campsite in Texas with a nasal irrigation device. US news outlet CBS News reported that the 71-year-old woman had previously been healthy before developing severe symptoms, including fever, headache and altered mental status, within four days of using the device. According to a report published by the US Centres for Disease Control and Prevention (CDC), the rare but often fatal brain infection, called primary amebic meningoencephalitis (PAM), was caused by the Naegleria fowleri organism. Despite medical treatment for a suspected PAM infection, she developed seizures and died eight days after the onset of symptoms. The US news outlet also reported that PAM is typically associated with recreational water activities, as the amoeba thrives in warm freshwater lakes, rivers and hot springs. Infection may occur if water containing the amoeba enters the nose and reaches the brain. The CDC recommends using distilled, sterile, or previously boiled and cooled tap water for nasal irrigation. When engaging in freshwater activities, the agency also advises using a nose clip or keeping one's head above water. The agency noted that the infection cannot be spread by drinking contaminated water or through person-to-person contact.


Borneo Post
2 days ago
- Borneo Post
Lingering shadow: Why Covid-19's return demands vigilance, not panic
Just when we thought the coast was clear, the familiar shadow of Covid-19 has returned. Just when we thought the coast was clear, the familiar shadow of Covid-19 has returned, uninvited, to our headlines and our communities. For months, we've enjoyed a semblance of normalcy – masks tucked away, social calendars full, and the virus relegated to a footnote. But recent reports from Thailand, Singapore, Malaysia, Hong Kong, and the US, all echoing the World Health Organization's (WHO) warnings, deliver an urgent, undeniable message: the pandemic's final act hasn't been written yet. This new surge, born from a cocktail of public fatigue, fading immunity, and viral evolution, demands a rapid recalibration of our approach. Not panic, but a sharp, intelligent focus on risk-based vigilance. The numbers are speaking volumes. Thailand's astonishing nearly 66,000 new cases in six days; Singapore's over 14,000 in a similar period; and Malaysia's consistent weekly average of 600, leading to over 11,000 cases in early 2025 – these are not minor fluctuations. The WHO's global confirmation of an 11% test positivity rate, a level not seen since mid-2024, signals a widespread upward trend, particularly across Southeast Asia and the Western Pacific. This resurgence is happening because people have become lax. Our reduced masking increased social mixing, and critically, the natural waning of both vaccine and infection-acquired immunity has created the perfect storm for transmission. The primary driver of this current surge is the NB.1.8.1 variant, now officially a WHO Variant Under Monitoring. Its defining characteristic is high transmissibility, allowing it to outcompete previous variants quickly, and now represents over 10% of global sequences. However, and this is a crucial point to understand amidst the alarm, NB.1.8.1 does not appear more virulent. Medical experts confirm there's no clear evidence it leads to higher hospitalization or death rates than its predecessors. Moreover, our existing vaccines are still holding strong, especially in preventing severe disease. Grasping this distinction – easily transmissible but not more severe – is key to a calm, effective response. So, what's the urgent takeaway for you? It's about shifting from a generalized 'over' mindset to informed, risk-based action. While the general, vaccinated population may experience symptoms akin to a bad cold, vulnerable groups face significantly higher risks of severe complications. If you or someone you care for falls into categories like the elderly, young children, pregnant individuals, or those with underlying health conditions (diabetes, heart disease, etc.), immediate heightened precautions are non-negotiable. For these vulnerable individuals, the action plan is simple and crucial: · Mask Up: In crowded indoor areas, or if you feel unwell. · Monitor and Test: Be acutely aware of symptoms. With flu, respiratory syncytial virus (RSV), and adenovirus also circulating, prompt Covid-19 antigen testing is vital for proper diagnosis and management. · Consult Your Doctor: Seek early medical advice. High-risk individuals might need additional evaluations. Crucially, if you have chronic conditions, maintain strict adherence to your medication. · Stay Vaccinated: Ensure your boosters are current. The vaccines remain effective against current strains.


The Star
5 days ago
- The Star
Exclusive-CDC expert resigns from COVID vaccines advisory role, sources say
FILE PHOTO: Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed U.S. flag in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) -Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos of the U.S. CDC resigned on Tuesday as co-leader of a working group that advises outside experts on COVID-19 vaccines and is leaving the agency, two sources familiar with the move told Reuters. Panagiotakopoulos said in an email to work group colleagues that her decision to step down was based on the belief she is "no longer able to help the most vulnerable members" of the U.S. population. In her role at the Centers for Disease Control and Prevention's working group of the Advisory Committee on Immunization Practices, she co-led the gathering of information on topics for presentation. Her resignation comes one week after Health Secretary Robert F. Kennedy Jr., a long-time vaccine skeptic who oversees the CDC, the Food and Drug Administration and the National Institutes of Health, said the COVID vaccine for healthy children and healthy pregnant women had been removed from the CDC's recommended immunization schedule. The move was a departure from the process in which ACIP experts meet and vote on changes to the immunization schedule or recommendations on who should get vaccines before the agency's director made a final call. The committee had not voted on the changes announced by Kennedy and the CDC does not yet have a permanent director. Two days after Kennedy's announcement, the CDC published a vaccine schedule online saying that COVID-19 vaccines remain an option for healthy children aged 6 months to 17 years when parents and doctors agree that it is needed. It had previously recommended updated COVID vaccines foreveryone aged six months and older, following the guidance ofthe panel of outside experts. Two sources said Panagiotakopoulos did not include a specific reason for her departure. Panagiotakopoulos did not return requests for comment. "Unfortunately for me, this is a personal decision," Panagiotakopoulos wrote in an email to members of the working group that was read to Reuters by a source who received it. "My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role." The committee is scheduled to meet on June 25-27 and is expected to deliberate and vote on recommendations for use of COVID-19 vaccines, according to one of the sources who was not authorized to speak publicly. (Reporting by Julie Steenhuysen in Chicago, Michael Erman in New York and Dan Levine in San Francisco; Editing by Caroline Humer and Bill Berkrot)